ADC Symposium Proceedings
24 August 2026
No Comments
AGENDA Two days dedicated to discussion and insights into the latest developments in the
Issue: Vol. 44
The patentability of intermediate chemical compounds
20 August 2026
No Comments
Introduction The majority of chemical reactions are sequential processes, involving a series of steps,
Artificial Intelligence in the Biopharma Industry
20 August 2026
No Comments
Artificial Intelligence (AI) is rapidly transforming the biopharmaceutical industry, reshaping how drugs are discovered,
AI at Enterprise Scale: Inside Pharma’s Manufacturing Transformation
20 August 2026
No Comments
Introduction: The Digital Maturity Paradox The global pharmaceutical and biopharmaceutical manufacturing sectors stand at
From data to decisions: How AI is transforming supply chains in chemical and pharmaceutical manufacturing
20 August 2026
No Comments
Introduction Supply chains in the chemical and pharmaceutical industries are becoming increasingly volatile, complex
Baxdrostat (Baxfendy)
19 August 2026
No Comments
Selectively blocking aldosterone production has been one of the harder problems in cardiovascular medicinal
Advancing Antibody–Peptide Conjugates Through Controlled Conjugation and High Product Homogeneity
19 August 2026
No Comments
Introduction Antibody–peptide conjugates (APCs) are gaining significant attention as a next-generation bioconjugate modality that
Regulatory affairs as the connective tissue of pharmaceutical product data
19 August 2026
No Comments
Arguably no pharma function has as complete a picture of a medicine across its
Scaling, Adapting and Partnering: How Europe’s Chemical Sector Can Stay Competitive in a Changing World
19 August 2026
No Comments
At Chemspec Europe 2026, I joined a panel with industry leaders to discuss a
HPAPI Management: From Categorization to Prevention – Practical Insights from the Spanish NTP 1104 & 1105 Framework
19 August 2026
No Comments
Introduction Highly Potent Active Pharmaceutical Ingredients (HPAPIs) have gained strategic importance across multiple therapeutic